Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) Sees Significant Increase in Short Interest

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 400,000 shares, a growth of 300.0% from the February 28th total of 100,000 shares. Based on an average daily trading volume, of 23,757,600 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company’s shares are sold short.

Endonovo Therapeutics Price Performance

OTCMKTS:ENDV traded down $0.00 on Friday, reaching $0.00. The company’s stock had a trading volume of 25,112 shares, compared to its average volume of 31,113,322. Endonovo Therapeutics has a 1-year low of $0.00 and a 1-year high of $0.00.

About Endonovo Therapeutics

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.